Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention. Wash hands after use. Adverse reactions (frequency and seriousness) Use of the product may occasionally result in pain on injection and/or local tissue reactions. Use during pregnancy, lactation or lay The product may be used in pregnant animals, subject to observance of the withholding time for milk and the withdrawal time for meat intended for human consumption. Interaction with other medicinal products and other forms of interaction None known. Amounts to be administered and administration route By either intramuscular or subcutaneous injection in dogs and cats, and by intramuscular injection only in cattle and pigs, at a dosage rate of 8.75 mg/kg bodyweight (1 ml / 20 kg bodyweight) daily for 3-5 days. Shake the vial well before use. After injection, massage the injection site. Use a completely dry sterile needle and syringe. Swab the septum before removing each dose. For combined therapy, the following minimum treatment regime should be followed: Synulox RTU Synulox LC 8.75 mg/kg bodyweight (7.0 mg One syringe gently infused into the amoxicillin, 1.75 mg clavulanic acid) teat of the infected quarter i.e. 1 ml/20 kg bodyweight
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention. Wash hands after use. Adverse reactions (frequency and seriousness) Use of the product may occasionally result in pain on injection and/or local tissue reactions. Use during pregnancy, lactation or lay The product may be used in pregnant animals, subject to observance of the withholding time for milk and the withdrawal time for meat intended for human consumption. Interaction with other medicinal products and other forms of interaction None known. Amounts to be administered and administration route By either intramuscular or subcutaneous injection in dogs and cats, and by intramuscular injection only in cattle and pigs, at a dosage rate of 8.75 mg/kg bodyweight (1 ml / 20 kg bodyweight) daily for 3-5 days. Shake the vial well before use. After injection, massage the injection site. Use a completely dry sterile needle and syringe. Swab the septum before removing each dose. For combined therapy, the following minimum treatment regime should be followed: Synulox RTU Synulox LC 8.75 mg/kg bodyweight (7.0 mg amoxicillin, 1.75 mg clavulanic acid) i.e. 1 ml/20 kg bodyweight One syringe gently infused into the teat of the infected quarter
SPC_141401.DOCX